AEMD
Price
$0.57
Change
+$0.02 (+3.64%)
Updated
Dec 24 closing price
IART
Price
$22.13
Change
+$0.12 (+0.55%)
Updated
Dec 24 closing price
56 days until earnings call
Ad is loading...

AEMD vs IART

Header iconAEMD vs IART Comparison
Open Charts AEMD vs IARTBanner chart's image
Aethlon Medical
Price$0.57
Change+$0.02 (+3.64%)
Volume$1.31M
CapitalizationN/A
Integra LifeSciences Holdings
Price$22.13
Change+$0.12 (+0.55%)
Volume$133.1K
CapitalizationN/A
AEMD vs IART Comparison Chart
Loading...
AEMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AEMD vs. IART commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEMD is a Hold and IART is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (AEMD: $0.57 vs. IART: $22.13)
Brand notoriety: AEMD and IART are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AEMD: 40% vs. IART: 16%
Market capitalization -- AEMD: $4.4M vs. IART: $2.77B
AEMD [@Medical Specialties] is valued at $4.4M. IART’s [@Medical Specialties] market capitalization is $2.77B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AEMD’s FA Score shows that 1 FA rating(s) are green whileIART’s FA Score has 1 green FA rating(s).

  • AEMD’s FA Score: 1 green, 4 red.
  • IART’s FA Score: 1 green, 4 red.
According to our system of comparison, AEMD is a better buy in the long-term than IART.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AEMD’s TA Score shows that 6 TA indicator(s) are bullish while IART’s TA Score has 4 bullish TA indicator(s).

  • AEMD’s TA Score: 6 bullish, 4 bearish.
  • IART’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AEMD is a better buy in the short-term than IART.

Price Growth

AEMD (@Medical Specialties) experienced а +55.73% price change this week, while IART (@Medical Specialties) price change was -3.91% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.94%. For the same industry, the average monthly price growth was +1.17%, and the average quarterly price growth was +2.66%.

Reported Earning Dates

AEMD is expected to report earnings on Feb 14, 2024.

IART is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Medical Specialties (+0.94% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IART($2.77B) has a higher market cap than AEMD($4.4M). IART YTD gains are higher at: -49.185 vs. AEMD (-73.994). IART has higher annual earnings (EBITDA): 256M vs. AEMD (-12.28M). IART has more cash in the bank: 309M vs. AEMD (7.97M). AEMD has less debt than IART: AEMD (1.01M) vs IART (1.68B). IART has higher revenues than AEMD: IART (1.54B) vs AEMD (574K).
AEMDIARTAEMD / IART
Capitalization4.4M2.77B0%
EBITDA-12.28M256M-5%
Gain YTD-73.994-49.185150%
P/E RatioN/A41.30-
Revenue574K1.54B0%
Total Cash7.97M309M3%
Total Debt1.01M1.68B0%
FUNDAMENTALS RATINGS
AEMD vs IART: Fundamental Ratings
AEMD
IART
OUTLOOK RATING
1..100
9172
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9989
PRICE GROWTH RATING
1..100
4261
P/E GROWTH RATING
1..100
1007
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AEMD's Valuation (34) in the Medical Specialties industry is somewhat better than the same rating for IART (77). This means that AEMD’s stock grew somewhat faster than IART’s over the last 12 months.

AEMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as IART (100). This means that AEMD’s stock grew similarly to IART’s over the last 12 months.

IART's SMR Rating (89) in the Medical Specialties industry is in the same range as AEMD (99). This means that IART’s stock grew similarly to AEMD’s over the last 12 months.

AEMD's Price Growth Rating (42) in the Medical Specialties industry is in the same range as IART (61). This means that AEMD’s stock grew similarly to IART’s over the last 12 months.

IART's P/E Growth Rating (7) in the Medical Specialties industry is significantly better than the same rating for AEMD (100). This means that IART’s stock grew significantly faster than AEMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AEMDIART
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
66%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
52%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 6 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 1 day ago
62%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
Bearish Trend 6 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
64%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
View a ticker or compare two or three
Ad is loading...
AEMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRHBX24.080.24
+1.01%
Nuveen Small Cap Blend Idx I
SPWCX9.220.08
+0.88%
American Beacon Stephens Sm Cp Gr C
TGVNX30.280.26
+0.87%
TCW Relative Value Mid Cap N
RMFFX56.000.45
+0.81%
American Funds American Mutual R5
MERDX36.870.22
+0.60%
Meridian Growth Legacy

AEMD and

Correlation & Price change

A.I.dvisor tells us that AEMD and GNGBY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AEMD and GNGBY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AEMD
1D Price
Change %
AEMD100%
+2.88%
GNGBY - AEMD
26%
Poorly correlated
-0.12%
IDXX - AEMD
25%
Poorly correlated
+0.11%
CSTL - AEMD
25%
Poorly correlated
+0.87%
RBOT - AEMD
24%
Poorly correlated
-5.96%
IART - AEMD
24%
Poorly correlated
+0.55%
More

IART and

Correlation & Price change

A.I.dvisor indicates that over the last year, IART has been loosely correlated with MASI. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then MASI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IART
1D Price
Change %
IART100%
+0.55%
MASI - IART
45%
Loosely correlated
+0.48%
LUNG - IART
39%
Loosely correlated
-1.60%
AORT - IART
36%
Loosely correlated
+0.95%
QDEL - IART
36%
Loosely correlated
-0.18%
DXR - IART
35%
Loosely correlated
-4.22%
More